The two companies will combine digital platforms and health record systems to provide data on patient disease management.
UC Davis Health and Propeller Health have announced a new collaboration that will offer personalized treatment for high-risk patients with asthma and chronic obstructive pulmonary disease (COPD) aiming to improve their health outcomes.
As part of the collaboration, UC Davis Health will provide the Propeller program–including sensors, mobile app, web portal, and personalized support–to eligible patients, with eventual expansion to patients in other UC locations and UC affiliates. The sensors attach to a patient’s inhaler to capture unique signals that record events, such as medication usage or respiration. This data will be transmitted directly to UC Davis Health’s Epic® electronic health record (EHR) system to support patient enrollment and remote patient monitoring via single sign-on.
Clario and Strados Labs Announce Partnership
“Digital health devices and platforms are helping improve care for patients with chronic conditions, like COPD, by providing clinicians a more expansive view of our patient’s disease management,” said Brooks Kuhn, assistant professor of medicine and co-director of the Comprehensive COPD Clinic. “This collaboration will help us improve the clinical outcomes of our COPD patients by identifying the need for interventions early so we can avoid serious exacerbations, preserve their lung function and improve their quality of life.”
Continue reading this story here.
This is just the latest announcement that a company providing digital platforms is expanding. Last week, ixlayer announced it was increasing its collaborations with biopharma investors. The company provides support for digital therapeutics and decentralized clinical trials.
Vice president of innovation at ixlayer said that the decision will help amplify the impact of new health technologies.
For more news, click here.